title: Do guidelines for the prescribing and monitoring of leflunomide need to be modified?
authors.forename: S
authors.initials: S
authors.lastname: Rajakulendran
authors.forename: C
authors.initials: C
authors.lastname: Deighton
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000706:statistics & numerical data; D011307:Drug Prescriptions / Q000592:standards; D004739:England; D006801:Humans; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data
chemical_list: D018501:Antirheumatic Agents; D007555:Isoxazoles; D000077339:Leflunomide